Achmea B.V., a shareholder of Union health insurance company, and Dôvera health insurance company, a member of the Penta investment group, signed a share transfer agreement on July 14, 2026, marking a significant shift in the Slovak health insurance market. Under the agreement, Dôvera will acquire Union, with plans to merge the two entities into a single brand under the Dôvera name by 2027. The transaction is financed solely by Dôvera’s shareholders and will not utilize funds allocated for patient healthcare.
Regulatory oversight and the role of the European Commission
The Protimonopolný úrad (PMÚ) SR has confirmed it is not currently reviewing the transaction, as it has not received an official notification of concentration. The authority stated that because of the nature of the entities involved, the merger falls under the exclusive jurisdiction of the European Commission. Participants are expected to seek pre-notification contact with the Commission to proceed. Historically, the insurance companies have maintained that public health insurance in Slovakia does not constitute a business, arguing that Union does not meet the legal definition of an entrepreneur.
Did You Know? The planned acquisition follows a two-phase process: Dôvera will first become the owner of Union after receiving regulatory approvals, followed by a formal merger of the two companies in 2027.
Political opposition and market concentration concerns
The announcement has drawn criticism from opposition parties, including SaS, PS, KDH, and Hnutie Slovensko. Critics warn of a potential “duopoly” and market monopolization, noting that the merger would allow a single financial group to control nearly half of the public health insurance market. Opposition leaders expressed concern regarding the vertical integration of the group, which already owns hospitals, clinics, and pharmacies, and have called on the PMÚ, the Health Care Surveillance Authority, and the government to investigate the implications for healthcare accessibility.
Integration plans and impact on policyholders
Dôvera CEO Martin Kultan stated that the company intends to integrate the best benefits from both insurers to offer them to all clients after the merger. For now, Union policyholders will see no changes to their services, benefits, or provider networks. Kultan rejected claims that the merger would limit competition, emphasizing that the focus on service quality and benefit development will remain a priority. All existing contractual rights and obligations with partners will continue to be honored throughout the transition.
Expert Insight: The stakes for the Slovak healthcare system are high, as the Ministry of Health acts as the primary regulator. The Ministry has publicly stated its intent to use all legal competencies to ensure that public health insurance funds are spent in the public interest and to maintain stable, sustainable healthcare delivery, regardless of the ownership structure.
Frequently Asked Questions
Will the Union brand disappear entirely?
No. While the insurance entities will merge under the Dôvera brand in 2027, the Union brand will remain active on the market, specifically focusing on commercial insurance.
Do current Union policyholders need to take action?
No. According to Dôvera, clients do not need to take any steps at this time, and they may continue to use their existing services, benefits, and provider networks as usual.
Who is responsible for approving this merger?
The transaction is subject to the review of independent bodies, including the European Commission, which holds exclusive jurisdiction over the concentration of these entities.
How might the proposed vertical integration of insurance and healthcare facilities influence the quality of care for the average patient?
Worth a look
